Search

Your search keyword '"Weischer M."' showing total 112 results

Search Constraints

Start Over You searched for: Author "Weischer M." Remove constraint Author: "Weischer M."
112 results on '"Weischer M."'

Search Results

1. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

2. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0).

3. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

4. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

5. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

6. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

7. Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

8. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

9. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer

10. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

11. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer

12. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

13. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

14. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

15. Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort

16. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

17. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

19. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

20. Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer

21. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

22. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression

23. CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

24. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression

25. Response

32. Chemical and physiological properties of the natural tranquilliser in the cephalopod eggs

33. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

37. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

38. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

39. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

40. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

41. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

42. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

43. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

44. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.

45. High tobacco consumption is causally associated with increased all-cause mortality in a general population sample of 55,568 individuals, but not with short telomeres: a Mendelian randomization study.

46. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.

47. Increased body mass index, elevated C-reactive protein, and short telomere length.

48. Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4,576 general population individuals with repeat measurements 10 years apart.

49. Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer.

50. CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.

Catalog

Books, media, physical & digital resources